PASO ROBLES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CASTLEMAN DISEASE COLLABORATIVE NETWORK, founded in 2005, is a small nonprofit in the Medical Research sector that reported $979K in total revenue in fiscal year 2024. Revenue fell 23% from the prior year — a significant decline worth monitoring. Net assets of $3.0M represent 36 months of operating reserves.
TO DEVELOP AWARENESS OF CASTLEMAN'S DISEASE AND TO RAISE MONEY TO FUND EDUCATION AND LABORATORY RESEARCH TO DETERMINE CAUSE, TREATMENT AND ULTIMATE CURE.
IN 2024, COMMUNITY CONTRIBUTIONS, LARGE GRANTS AND FUNDRAISER PROCEEDS WERE RECEIVED AND USED TO HELP FUND A CASTLEMAN'S DISEASE EDUCATIONAL CONFERENCE HELD IN DECEMBER 2024 IN SAN DIEGO, CALIFORNIA...
IN 2024, COMMUNITY CONTRIBUTIONS, LARGE GRANTS AND FUNDRAISER PROCEEDS WERE RECEIVED AND USED TO HELP FUND A CASTLEMAN'S DISEASE EDUCATIONAL CONFERENCE HELD IN DECEMBER 2024 IN SAN DIEGO, CALIFORNIA. THE CDCN (CASTLEMAN'S DISEASE COLLABORATIVE NETWORK) HELD THE 13TH ANNUAL "ACCELERATING RESEARCH & TREATMENT FOR CASTLEMAN'S DISEASE WORKING DINNER" WHERE A DIVERSE GROUP OF HEMATOLOGISTS, PATHOLOGISTS, PHYSICIAN-SCIENTISTS, TRANSLATIONAL RESEARCHERS AND PHARMACEUTICAL PARTNERS ATTENDED. THE MEETING FOCUSED ON THE GAPS THAT EXIST IN THE CURRENT STATE OF KNOWLEDGE REGARDING THE DISEASE, DIAGNOSTIC CRITERIA AND RECENTLY APPROVED TREATMENT OPTIONS. FUNDS WERE EXPENDED FOR FACILITY RENTAL, TRAVEL, LODGING MEALS AND OTHER RELATED EXPENSES.THE FUNDS WERE ALSO USED TO SUPPORT AN EDUCATIONAL SUMMIT MEETING HELD IN JULY 2024 IN PHILADELPHIA, PENNSYLVANIA FOR PATIENTS AND LOVED ONES DEALING WITH CASTLEMAN'S DISEASE. THE PURPOSE OF THIS MEETING WAS TO PROVIDE SUPPORTIVE RESOURCES, UP TO DATE INFORMATION ABOUT THE DISEASE, CURRENT RESEARCH AND TREATMENT OPTIONS AND WAYS TO SUPPORT THE EFFORTS IN THESE AREAS. FUNDS WERE EXPENDED FOR PROMOTION, PATIENT LITERATURE, LODGING, TRAVEL AND OTHER RELATED EXPENSES.TO SUPPORT THE ONGOING RESEARCH FOR CASTLEMAN'S DISEASE CAUSE AND TREATMENT:IN 2024, CASH CONTRIBUTIONS TOTALING $298,000 WERE MADE TO THE UNIVERSITY OF PENNSYLVANIA AND THE UPLIFTING ATHLETES ORGANIZATION. THESE CASH CONTRIBUTIONS WERE MADE TO FUND FURTHER RESEARCH IN CASTLEMAN'S DISEASE. IN 2024 CASH EXPENDITURES OF $537,833 WERE MADE TO COVER CONSULTING FEES, PHYSICIAN EDUCATION, PATIENT EDUCATION AND MAINTAIN A DATABASE FOR RESEARCH TEAMS INVOLVED IN VARIOUS AREAS OF CASTLEMAN'S DISEASE RESEARCH. THESE RESEARCH STUDIES OFFER PROMISE TO UNDERSTAND THE CASTLEMAN'S DISEASE MECHANISMS AND PROVIDE INSIGHTS FOR DEVELOPMENT OF PERSONALIZED THERAPIES.IN 2025, FURTHER COMMUNITY CONTRIBUTION SOLICITATIONS AND FUNDRAISING EVENTS ARE PLANNED SO THAT MORE MONEY IS AVAILABLE TO FURTHER FUND THE EDUCATION, RESEARCH, CAUSE AND CURE OF CASTLEMAN'S DISEASE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $979,030 | $1,265,979 | -0.2% |
| Expenses | $961,126 | $827,118 | +0.2% |
| Net Income | $17,904 | $438,861 | -1.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KATHERINE HAEUSEL | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| KEVIN SILK | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| BETTE JACOBS | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| PETER BUCKMAN | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| TIM HUVAL | Director | 0.00 |
Director
|
$0 | $0 | $0 |
| CHARLYN PACHECO | Secretary | 0.00 |
Officer
|
$0 | $0 | $0 |
| GREG PACHECO | Chairman | 0.00 |
Officer
|
$0 | $0 | $0 |
| JASON CLARK DIEFENDERFER | Vice President | 0.00 |
Officer
|
$0 | $0 | $0 |
| DAVID FAJGENBAUM | President | 0.00 |
Officer
|
$0 | $0 | $0 |
| MICHAEL STIEF | Treasurer | 0.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $979,030 | $961,126 | $2,977,786 | $17,904 |
| 2023 | $1,265,979 | $827,118 | $2,959,883 | $438,861 |
| 2022 | $898,672 | $442,509 | $2,521,021 | $456,163 |
| 2021 | $788,631 | $670,727 | $2,064,859 | $117,904 |
| 2020 | $1,031,462 | $615,045 | $1,946,955 | $416,417 |
| 2019 | $1,184,161 | $603,315 | $1,530,537 | $580,846 |
Compare CASTLEMAN DISEASE COLLABORATIVE NETWORK with other nonprofits in California and across the country.